Quantcast
Last updated on April 17, 2014 at 9:33 EDT

Latest Avanafil Stories

2014-03-03 23:21:45

Transparency Market Research adds new "Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" market research report to its report store. Browse the report with request TOC; visit http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html Albany, NY (PRWEB) March 03, 2014 According to a new market report published by...

2014-02-19 08:29:55

-Company Marks Milestone of Two New Product Launches- CHESTERBROOK, Pa., Feb. 19, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York at 9:30 a.m. ET on February 26, 2014 to celebrate Auxilium's transformation into a leading men's healthcare company, including two recent launches of new products in men's healthcare, XIAFLEX®...

2013-12-27 04:21:44

DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3zf33c/erectile) have announced the addition of the "Global Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/3zf33c/erectile ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Erectile dysfunction (ED) is the...

2013-12-17 08:25:59

NEW YORK, December 17, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting MiMedx Group, Inc. (NASDAQ: MDXG), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), VIVUS Inc. (NASDAQ: VVUS), Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), and GenVec, Inc. (NASDAQ: GNVC). Today's readers may access these reports free of charge - including full price targets, industry...

2013-10-21 08:28:11

ALBANY, New York, October 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global erectile dysfunction drugs market was valued at USD 4.3 billion in 2012 and is expected to decline at a CAGR of (4.5%) from 2013 to 2019, to...

2013-10-11 08:23:42

- STENDRA Broadens Auxilium's Presence in Men's Health Care With a Projected 2013 Launch into the Multi-Billion Dollar Erectile Dysfunction Market - CHESTERBROOK, Pa., Oct. 11, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. (Nasdaq: VVUS) providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada. The...

2012-09-20 02:28:11

MOUNTAIN VIEW, Calif., Sept. 20, 2012 /PRNewswire/ -- VIVUS, Inc. (Nasdaq:VVUS) today announced that multiple scientific abstracts will be presented at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society, to be held September 20(th) to September 24(th) in San Antonio, Texas. The Obesity Society's Annual Scientific Meeting has grown to be one of the largest gatherings of obesity professionals worldwide. The posters will be displayed in Exhibit Hall C of the Henry B....

FDA Approves New Drug For Erectile Dysfunction
2012-04-28 04:43:19

The US Food and Drug Administration (FDA) voted on Friday to approve a new drug to treat erectile dysfunction (ED), various media outlets have reported. The medication, Stendra (genetic name: avanafil), is produced by California-based pharmaceutical company Vivus Inc. and is the first product from that company to receive FDA approval, according to Jennifer Corbett Dooren of the Wall Street Journal. Like Viagra, Cialis, and Levitra, Stendra is a phosphodiesterase type 5 (PDE-5) inhibitor...

2012-04-27 10:24:09

MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S. "Patients and treating physicians continue to report significant dissatisfaction with current treatments of ED,"...

2012-04-10 23:02:47

In an effort to educate the public about cutting-edge erectile dysfunction treatments, AccessRx.com, a leading online facilitator of prescription medications, has created a six-part series that investigates erectile dysfunction, including an in-depth article about future medications. (PRWEB) April 09, 2012 In an effort to educate the public about cutting-edge erectile dysfunction treatments, AccessRx.com, a leading online facilitator of prescription medications, has created a six-part...